Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call Business Wire - Wed Jul 22, 3:05PM CDT

Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on July 29, 2026. The company will also host a conference...

CORT : 95.36 (-1.34%)
CORT
3 Cash-Heavy Stocks with Questionable Fundamentals StockStory - Mon Jul 6, 11:35PM CDT

3 Cash-Heavy Stocks with Questionable Fundamentals

CORT : 95.36 (-1.34%)
EFSC : 65.99 (+1.46%)
DLB : 49.86 (+1.42%)
DNUT
3 High-Flying Stocks We Steer Clear Of StockStory - Mon Jun 29, 11:33PM CDT

3 High-Flying Stocks We Steer Clear Of

CORT : 95.36 (-1.34%)
SEI : 54.03 (-10.52%)
DNUT : 3.15 (+1.29%)
Kuehn Law Encourages Investors of Corcept Therapeutics Incorporated to Contact Law Firm PR Newswire - Thu Jun 25, 5:41PM CDT

NEW YORK , June 25, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Corcept Therapeutics Incorporated (NASDAQ:...

CORT : 95.36 (-1.34%)
ASYS
3 Unpopular Stocks We Steer Clear Of StockStory - Mon Jun 22, 11:36PM CDT

3 Unpopular Stocks We Steer Clear Of

CORT : 95.36 (-1.34%)
ASYS : 15.89 (-7.88%)
AAL : 14.48 (+6.79%)
Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome Business Wire - Wed Jun 17, 3:28PM CDT

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic...

CORT : 95.36 (-1.34%)
Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym® Business Wire - Sat Jun 6, 3:45PM CDT

New data from CATALYST and MOMENTUM trials presented at American Diabetes Association’s (ADA) 86 th Scientific Sessions In the CATALYST trial, patients with...

CORT : 95.36 (-1.34%)
CENT
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Question StockStory - Sun May 31, 11:36PM CDT

1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Question

CORT : 95.36 (-1.34%)
CENT : 43.75 (+1.79%)
G : 31.26 (+2.93%)
Corcept Presents New Data at ASCO 2026: Lifyorli™ Overall Survival Across All Subgroups of Patients with Platinum-Resistant Ovarian Cancer, Including Those with Recent Taxane Exposure Business Wire - Fri May 29, 3:33PM CDT

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic...

CORT : 95.36 (-1.34%)
Corcept to Resubmit its New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome Business Wire - Wed May 27, 7:00AM CDT

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic...

CORT : 95.36 (-1.34%)

Barchart Exclusives

No Matter Who Wins the Smartphone and AI Chip Races, ARM Stock Still Benefits Barchart - Sat Jul 25, 2:30PM CDT
Arm now leads x86 in AI servers and collects royalties from every chipmaker, including the ones it competes with. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.